[Rituximab to treat ANCA-associated vasculitis]

Rev Med Interne. 2011 Oct;32(10):591-3. doi: 10.1016/j.revmed.2011.07.001. Epub 2011 Aug 26.
[Article in French]
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / drug therapy*
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Cyclophosphamide / therapeutic use
  • Humans
  • Immunologic Factors / therapeutic use*
  • Immunosuppressive Agents / therapeutic use
  • Neoplasms / chemically induced
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Immunosuppressive Agents
  • Rituximab
  • Cyclophosphamide